Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-28 Sale | 2021-03-04 5:00 pm | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 5,344 | $62.93 | $336,297 | 233,094 (Direct) | View |
| 2020-10-16 Sale | 2020-10-20 4:52 pm | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 37,851 | $38.16 | $1,444,206 | 306,521 (Direct) | View |
| 2020-10-13 Sale | 2020-10-13 5:43 pm | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 1,649 | $40 | $65,960 | 145,917 (Direct) | View |
| 2020-06-01 Sale | 2020-06-03 4:57 pm | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 20,000 | $26.35 | $527,037 | 85,389 (Direct) | View |
| 2020-05-22 Sale | 2020-05-26 5:58 pm | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 7,500 | $30 | $225,000 | 147,566 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-02 Option Award | 2021-03-04 5:00 pm | N/A 2031-03-01 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 40,800 | $0 | 233,094 (Direct) | View |
| 2020-12-28 Exercise | 2021-03-04 5:00 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 13,195 | $0 | 233,094 (Direct) | View |
| 2020-12-28 Exercise | 2021-03-04 5:00 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 13,195 | $0.6 | 233,094 (Direct) | View |
| 2020-10-19 Exercise | 2020-10-20 4:52 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 1,503 | $2.19 | 306,521 (Direct) | View |
| 2020-10-16 Exercise | 2020-10-20 4:52 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 37,851 | $0 | 306,521 (Direct) | View |
| 2020-10-16 Exercise | 2020-10-20 4:52 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 36,348 | $0.6 | 306,521 (Direct) | View |
| 2020-10-13 Exercise | 2020-10-13 5:43 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 1,649 | $0 | 145,917 (Direct) | View |
| 2020-10-13 Exercise | 2020-10-13 5:43 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 1,649 | $0.6 | 145,917 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:57 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 20,000 | $2.19 | 85,389 (Direct) | View |
| 2020-06-01 Exercise | 2020-06-03 4:57 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 20,000 | $0 | 85,389 (Direct) | View |
| 2020-05-22 Exercise | 2020-05-26 5:58 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 7,500 | $0 | 147,566 (Direct) | View |
| 2020-05-22 Exercise | 2020-05-26 5:58 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 7,500 | $0.6 | 147,566 (Direct) | View |
| 2019-12-20 Exercise(A) | 2020-05-26 5:57 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 13,500 | $0 | 290,632 (Direct) | View |
| 2019-12-20 Exercise | 2020-04-15 7:33 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 13,500 | $0 | 304,132 (Direct) | View |
| 2019-12-20 Exercise | 2020-04-15 7:33 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 13,500 | $0.6 | 304,132 (Direct) | View |
| 2020-03-25 Option Award | 2020-03-26 6:04 pm | N/A 2030-03-24 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP Research & Preclinical Dev | 42,000 | $0 | 42,000 (Direct) | View |
Ownership | 2019-06-18 9:39 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Liau Gene EVP, Head of Research | 0 | $0 | 246,955 (Direct) | View |